{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "inhibition activity", "management", "mechanism of enzyme", "natural compound"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35807418", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "29"}], "Language": ["eng"], "ELocationID": ["4175", "10.3390/molecules27134175"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "13", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "29"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer's Disease.", "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is a progressive neurological condition. The rising prevalence of AD necessitates the rapid development of efficient therapy options. Despite substantial study, only a few medications are capable of delaying the disease. Several substances with pharmacological activity, derived from plants, have been shown to have positive benefits for the treatment of AD by targeting various enzymes, such as acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), \u03b2-secretase, \u03b3-secretase, and monoamine oxidases (MAOs), which are discussed as potential targets. Medicinal plants have already contributed a number of lead molecules to medicine development, with many of them currently undergoing clinical trials. A variety of medicinal plants have been shown to diminish the degenerative symptoms associated with AD, either in their raw form or as isolated compounds. The aim of this review was to provide a brief summary of AD and its current therapies, followed by a discussion of the natural compounds examined as therapeutic agents and the processes underlying the positive effects, particularly the management of AD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Convalescent Area, Ningbo Psychiatric Hospital, Ningbo 315040, China."}], "LastName": "Wang", "ForeName": "Shanshan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Convalescent Area, Ningbo Psychiatric Hospital, Ningbo 315040, China."}], "LastName": "Kong", "ForeName": "Xianbo", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cadre Ward, 906 Hospital of the Chinese People's Liberation Army, Ningbo 315040, China."}], "LastName": "Chen", "ForeName": "Zhangjing", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Five Disease Areas, Ningbo Psychiatric Hospital, Ningbo 315040, China."}], "LastName": "Wang", "ForeName": "Guopin", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Inspection, Ningbo Psychiatric Hospital, Ningbo 315040, China."}], "LastName": "Zhang", "ForeName": "Juan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurology, Sanya Central Hospital, Hainan Third People's Hospital, Sanya 572000, China."}], "LastName": "Wang", "ForeName": "Jing", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cholinesterase Inhibitors"}, {"RegistryNumber": "EC 3.1.1.7", "NameOfSubstance": "Acetylcholinesterase"}, {"RegistryNumber": "EC 3.1.1.8", "NameOfSubstance": "Butyrylcholinesterase"}], "MeshHeadingList": [{"QualifierName": ["therapeutic use"], "DescriptorName": "Acetylcholinesterase"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Butyrylcholinesterase"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Cholinesterase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Dey A., Bhattacharya R., Mukherjee A., Pandey D.K. Natural products against Alzheimer\u2019s disease: Pharmaco-therapeutics and biotechnological interventions. Biotechnol. Adv. 2017;35:178\u2013216. doi: 10.1016/j.biotechadv.2016.12.005.", "ArticleIdList": ["10.1016/j.biotechadv.2016.12.005", "28043897"]}, {"Citation": "Noetzli M., Eap C.B. Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer\u2019s Disease. Clin. Pharmacokinet. 2013;52:225\u2013241. doi: 10.1007/s40262-013-0038-9.", "ArticleIdList": ["10.1007/s40262-013-0038-9", "23408070"]}, {"Citation": "Armstrong R.A. Review article What causes alzheimer\u2019s disease? Folia Neuropathol. 2013;3:169\u2013188. doi: 10.5114/fn.2013.37702.", "ArticleIdList": ["10.5114/fn.2013.37702", "24114635"]}, {"Citation": "Scheltens P., Blennow K., Breteler M.M., de Strooper B., Frisoni G.B., Salloway S., van der Flier W.M. Alzheimer\u2019s disease. Lancet. 2016;388:505\u2013517. doi: 10.1016/S0140-6736(15)01124-1.", "ArticleIdList": ["10.1016/S0140-6736(15)01124-1", "26921134"]}, {"Citation": "Alzheimer\u2019s Association 2021 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2021;17:327\u2013406. doi: 10.1002/alz.12328.", "ArticleIdList": ["10.1002/alz.12328", "33756057"]}, {"Citation": "Iqubal A., Rahman S.O., Ahmed M., Bansal P., Haider R., Iqubal M.K., Najmi A.K., Pottoo F.H., Haque S.E. Current Quest in Natural Bioactive Compounds for Alzheimer\u2019s Disease: Multi-Targeted-Designed-Ligand Based Approach with Preclinical and Clinical Based Evidence. Curr. Drug Targets. 2021;22:685\u2013720. doi: 10.2174/1389450121999201209201004.", "ArticleIdList": ["10.2174/1389450121999201209201004", "33302832"]}, {"Citation": "Scheltens P., De Strooper B., Kivipelto M., Holstege H., Ch\u00e9telat G., Teunissen C.E., Cummings J., van der Flier W.M. Alzheimer\u2019s disease. Lancet. 2021;397:1577\u20131590. doi: 10.1016/S0140-6736(20)32205-4.", "ArticleIdList": ["10.1016/S0140-6736(20)32205-4", "PMC8354300", "33667416"]}, {"Citation": "Marucci G., Buccioni M., Ben D.D., Lambertucci C., Volpini R., Amenta F. Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease. Neuropharmacology. 2021;190:108352. doi: 10.1016/j.neuropharm.2020.108352.", "ArticleIdList": ["10.1016/j.neuropharm.2020.108352", "33035532"]}, {"Citation": "Andrade S., Ramalho M.J., Loureiro J.A., Pereira M.D.C. Natural Compounds for Alzheimer\u2019s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies. Int. J. Mol. Sci. 2019;20:2313. doi: 10.3390/ijms20092313.", "ArticleIdList": ["10.3390/ijms20092313", "PMC6539304", "31083327"]}, {"Citation": "Kaur D., Behl T., Sehgal A., Singh S., Sharma N., Bungau S. Multifaceted Alzheimer\u2019s Disease: Building a Roadmap for Advancement of Novel Therapies. Neurochem. Res. 2021;46:2832\u20132851. doi: 10.1007/s11064-021-03415-w.", "ArticleIdList": ["10.1007/s11064-021-03415-w", "34357520"]}, {"Citation": "Trottier G., Bostr\u00f6m P.J., Lawrentschuk N., Fleshner N.E. Nutraceuticals and prostate cancer prevention: A current review. Nat. Rev. Urol. 2009;7:21\u201330. doi: 10.1038/nrurol.2009.234.", "ArticleIdList": ["10.1038/nrurol.2009.234", "19997071"]}, {"Citation": "Zeisel S.H. Regulation of \u201cNutraceuticals\u201d. Science. 1999;285:1853\u20131855. doi: 10.1126/science.285.5435.1853.", "ArticleIdList": ["10.1126/science.285.5435.1853", "10515789"]}, {"Citation": "Sadhukhan P., Saha S., Dutta S., Mahalanobish S., Sil P.C. Nutraceuticals: An emerging therapeutic approach against the pathogenesis of Alzheimer\u2019s disease. Pharmacol. Res. 2018;129:100\u2013114. doi: 10.1016/j.phrs.2017.11.028.", "ArticleIdList": ["10.1016/j.phrs.2017.11.028", "29183770"]}, {"Citation": "Ahmad S.S., Khalid M., Kamal M.A., Younis K. Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer\u2019s Disease: A Review. Curr. Neuropharmacol. 2021;19:1. doi: 10.2174/1570159X19666210215122333.", "ArticleIdList": ["10.2174/1570159X19666210215122333", "PMC9185787", "33588732"]}, {"Citation": "Rodrigues T., Reker D., Schneider P., Schneider G. Counting on natural products for drug design. Nat. Chem. 2016;8:531\u2013541. doi: 10.1038/nchem.2479.", "ArticleIdList": ["10.1038/nchem.2479", "27219696"]}, {"Citation": "Woo J., Yang H., Yoon M., Gadhe C.G., Pae A.N., Cho S., Lee S.C.A.C.J. 3-Carene, a Phytoncide from Pine Tree Has a Sleep-enhancing Effect by Targeting the GABAA-benzodiazepine Receptors. Exp. Neurobiol. 2019;28:593\u2013601. doi: 10.5607/en.2019.28.5.593.", "ArticleIdList": ["10.5607/en.2019.28.5.593", "PMC6844839", "31698551"]}, {"Citation": "Vallianou I., Hadzopoulou-Cladaras M. Camphene, a Plant Derived Monoterpene, Exerts Its Hypolipidemic Action by Affecting SREBP-1 and MTP Expression. PLoS ONE. 2016;11:e0147117. doi: 10.1371/journal.pone.0147117.", "ArticleIdList": ["10.1371/journal.pone.0147117", "PMC4718691", "26784701"]}, {"Citation": "Girola N., Figueiredo C.R., Farias C.F., Azevedo R.A., Ferreira A.K., Teixeira S.F., Capello T.M., Martins E.G., Matsuo A.L., Travassos L.R., et al. Camphene isolated from essential oil of Piper cernuum (Piperaceae) induces intrinsic apoptosis in melanoma cells and displays antitumor activity in vivo. Biochem. Biophys. Res. Commun. 2015;467:928\u2013934. doi: 10.1016/j.bbrc.2015.10.041.", "ArticleIdList": ["10.1016/j.bbrc.2015.10.041", "26471302"]}, {"Citation": "Lenis-Rojas O.A., Robalo M.P., Tomaz A.I., Carvalho A., Fernandes A.R., Marques F., Folgueira M., Y\u00e1\u00f1ez J., V\u00e1zquez-Garc\u00eda D., Torres M.L., et al. RuII(p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity In Vivo. Inorg. Chem. 2018;57:13150\u201313166. doi: 10.1021/acs.inorgchem.8b01270.", "ArticleIdList": ["10.1021/acs.inorgchem.8b01270", "30339386"]}, {"Citation": "Hou J., Zhang Y., Zhu Y., Zhou B., Ren C., Liang S., Guo Y. \u03b1-Pinene Induces Apoptotic Cell Death via Caspase Activation in Human Ovarian Cancer Cells. Med. Sci. Monit. 2019;25:6631\u20136638. doi: 10.12659/MSM.916419.", "ArticleIdList": ["10.12659/MSM.916419", "PMC6743669", "31482864"]}, {"Citation": "Aydin E., T\u00fcrkez H., Ta\u015fdemir \u015e. Anticancer and Antioxidant Properties of Terpinolene in Rat Brain Cells. Arch. Ind. Hyg. Toxicol. 2013;64:415\u2013424. doi: 10.2478/10004-1254-64-2013-2365.", "ArticleIdList": ["10.2478/10004-1254-64-2013-2365", "24084350"]}, {"Citation": "Shin M., Liu Q.F., Choi B., Shin C., Lee B., Yuan C., Song Y.J., Yun H.S., Lee I.-S., Koo B.-S., et al. Neuroprotective Effects of Limonene (+) against A\u03b242-Induced Neurotoxicity in a Drosophila Model of Alzheimer\u2019s Disease. Biol. Pharm. Bull. 2020;43:409\u2013417. doi: 10.1248/bpb.b19-00495.", "ArticleIdList": ["10.1248/bpb.b19-00495", "31875578"]}, {"Citation": "Sabogal-Gu\u00e1queta A.M., Hobbie F., Keerthi A., Oun A., Kortholt A., Boddeke E., Dolga A. Linalool attenuates oxidative stress and mitochondrial dysfunction mediated by glutamate and NMDA toxicity. Biomed. Pharmacother. 2019;118:109295. doi: 10.1016/j.biopha.2019.109295.", "ArticleIdList": ["10.1016/j.biopha.2019.109295", "31545255"]}, {"Citation": "Islam A., Hellman B., Nyberg F., Amir N., Jayaraj R., Petroainu G., Adem A. Myrcene Attenuates Renal Inflammation and Oxidative Stress in the Adrenalectomized Rat Model. Molecules. 2020;25:4492. doi: 10.3390/molecules25194492.", "ArticleIdList": ["10.3390/molecules25194492", "PMC7582976", "33007969"]}, {"Citation": "Du Y., Luan J., Jiang R.P., Liu J., Ma Y. Myrcene exerts anti-asthmatic activity in neonatal rats via modulating the matrix remodeling. Int. J. Immunopathol. Pharmacol. 2020;34:2058738420954948. doi: 10.1177/2058738420954948.", "ArticleIdList": ["10.1177/2058738420954948", "PMC7517990", "32962470"]}, {"Citation": "Kumar A., Agarwal K., Singh M., Saxena A., Yadav P., Maurya A.K., Yadav A., Tandon S., Chanda D., Bawankule D.U. Essential oil from waste leaves of Curcuma longa L. alleviates skin inflammation. Inflammopharmacology. 2018;26:1245\u20131255. doi: 10.1007/s10787-018-0447-3.", "ArticleIdList": ["10.1007/s10787-018-0447-3", "29429001"]}, {"Citation": "Baldissera M.D., Grando T.H., Souza C.F., Gressler L.T., Stefani L.M., da Silva A.S., Monteiro S.G. In vitro and in vivo action of terpinen-4-ol, \u03b3-terpinene, and \u03b1-terpinene against Trypanosoma evansi. Exp. Parasitol. 2016;162:43\u201348. doi: 10.1016/j.exppara.2016.01.004.", "ArticleIdList": ["10.1016/j.exppara.2016.01.004", "26773165"]}, {"Citation": "Falk A., L\u00f6f A., Hagberg M., Hjelm E.W., Wang Z. Human exposure to 3-carene by inhalation: Toxicokinetics, effects on pulmonary function and occurrence of irritative and CNS symptoms. Toxicol. Appl. Pharmacol. 1991;110:198\u2013205. doi: 10.1016/S0041-008X(05)80002-X.", "ArticleIdList": ["10.1016/S0041-008X(05)80002-X", "1891768"]}, {"Citation": "Schlumpf M., Durrer S., Faass O., Ehnes C., Fuetsch M., Gaille C., Henseler M., Hofkamp L., Maerkel K., Reolon S., et al. Developmental toxicity of UV filters and environmental exposure: A review. Int. J. Androl. 2008;31:144\u2013151. doi: 10.1111/j.1365-2605.2007.00856.x.", "ArticleIdList": ["10.1111/j.1365-2605.2007.00856.x", "18194281"]}, {"Citation": "D\u00f6rsam B., Wu C.-F., Efferth T., Kaina B., Fahrer J. The eucalyptus oil ingredient 1,8-cineol induces oxidative DNA damage. Arch. Toxicol. 2014;89:797\u2013805. doi: 10.1007/s00204-014-1281-z.", "ArticleIdList": ["10.1007/s00204-014-1281-z", "24912782"]}, {"Citation": "Ravichandran C., Badgujar P.C., Gundev P., Upadhyay A. Review of toxicological assessment of d-limonene, a food and cosmetics additive. Food Chem. Toxicol. 2018;120:668\u2013680. doi: 10.1016/j.fct.2018.07.052.", "ArticleIdList": ["10.1016/j.fct.2018.07.052", "30075315"]}, {"Citation": "Audrain H., Kenward C., Lovell C., Green C., Ormerod A., Sansom J., Chowdhury M., Cooper S., Johnston G., Wilkinson S.M., et al. Allergy to oxidized limonene and linalool is frequent in the U.K. Br. J. Dermatol. 2014;171:292\u2013297. doi: 10.1111/bjd.13037.", "ArticleIdList": ["10.1111/bjd.13037", "24702129"]}, {"Citation": "De Groot A.C., Schmidt E. Tea tree oil: Contact allergy and chemical composition. Contact Dermat. 2016;75:129\u2013143. doi: 10.1111/cod.12591.", "ArticleIdList": ["10.1111/cod.12591", "27173437"]}, {"Citation": "Kuboyama T., Tohda C., Komatsu K. Effects of Ashwagandha (Roots of Withania somnifera) on Neurodegenerative Diseases. Biol. Pharm. Bull. 2014;37:892\u2013897. doi: 10.1248/bpb.b14-00022.", "ArticleIdList": ["10.1248/bpb.b14-00022", "24882401"]}, {"Citation": "Corona J.C. Natural Compounds for the Management of Parkinson\u2019s Disease and Attention-Deficit/Hyperactivity Disorder. BioMed Res. Int. 2018;2018:1\u201312. doi: 10.1155/2018/4067597.", "ArticleIdList": ["10.1155/2018/4067597", "PMC6282143", "30596091"]}, {"Citation": "Rehman M.U., Wali A.F., Ahmad A., Shakeel S., Rasool S., Ali R., Rashid S.M., Madkhali H., Ganaie M.A., Khan R. Neuroprotective Strategies for Neurological Disorders by Natural Products: An update. Curr. Neuropharmacol. 2019;17:247\u2013267. doi: 10.2174/1570159X16666180911124605.", "ArticleIdList": ["10.2174/1570159X16666180911124605", "PMC6425075", "30207234"]}, {"Citation": "de Ara\u00fajo F.F., de Paulo Farias D., Neri-Numa I.A., Pastore G.M. Polyphenols and their applications: An approach in food chemistry and innovation potential. Food Chem. 2020;338:127535. doi: 10.1016/j.foodchem.2020.127535.", "ArticleIdList": ["10.1016/j.foodchem.2020.127535", "32798817"]}, {"Citation": "Silman I., Sussman J.L. Acetylcholinesterase: How is structure related to function? Chem. Interactions. 2008;175:3\u201310. doi: 10.1016/j.cbi.2008.05.035.", "ArticleIdList": ["10.1016/j.cbi.2008.05.035", "18586019"]}, {"Citation": "Lane R.M., Kivipelto M., Greig N.H. Acetylcholinesterase and Its Inhibition in Alzheimer Disease. Clin. Neuropharmacol. 2004;27:141\u2013149. doi: 10.1097/00002826-200405000-00011.", "ArticleIdList": ["10.1097/00002826-200405000-00011", "15190239"]}, {"Citation": "Lv M., Xu H. Acetylcholinesterase: A Primary Target for Drugs and Insecticides. Mini-Rev. Med. Chem. 2017;17:1665\u20131676. doi: 10.2174/1389557517666170120153930.", "ArticleIdList": ["10.2174/1389557517666170120153930", "28117022"]}, {"Citation": "Ahmad S.S., Younis K., Philippe J., Aschner M., Khan H. Strategic approaches to target the enzymes using natural compounds for the management of Alzheimer\u2019s disease: A review. CNS Neurol. Disord. Drug Targets. 2021;21:610\u2013620. doi: 10.2174/1871527320666210811160007.", "ArticleIdList": ["10.2174/1871527320666210811160007", "34382514"]}, {"Citation": "Shah A.A., Dar T.A., Dar P.A., Ganie S.A., Kamal M.A. A Current Perspective on the Inhibition of Cholinesterase by Natural and Synthetic Inhibitors. Curr. Drug Metab. 2017;18:96\u2013111. doi: 10.2174/1389200218666161123122734.", "ArticleIdList": ["10.2174/1389200218666161123122734", "27890007"]}, {"Citation": "Lee J.P., Kang M.-G., Lee J.Y., Oh J.M., Baek S.C., Leem H.H., Park D., Cho M.-L., Kim H. Potent inhibition of acetylcholinesterase by sargachromanol I from Sargassum siliquastrum and by selected natural compounds. Bioorganic Chem. 2019;89:103043. doi: 10.1016/j.bioorg.2019.103043.", "ArticleIdList": ["10.1016/j.bioorg.2019.103043", "31200287"]}, {"Citation": "Ferreira J., Santos S., Pereira H. In Vitro Screening for Acetylcholinesterase Inhibition and Antioxidant Activity of Quercus suber Cork and Corkback Extracts. Evid. Based Complement. Altern. Med. 2020;2020:1\u20138. doi: 10.1155/2020/3825629.", "ArticleIdList": ["10.1155/2020/3825629", "PMC7387968", "32765630"]}, {"Citation": "Cespedes C.L., Mu\u00f1oz E., Salazar J.R., Yamaguchi L., Werner E., Alarcon J., Kubo I. Inhibition of cholinesterase activity by extracts, fractions and compounds from Calceolaria talcana and C. integrifolia (Calceolariaceae: Scrophulariaceae) Food Chem. Toxicol. 2013;62:919\u2013926. doi: 10.1016/j.fct.2013.10.027.", "ArticleIdList": ["10.1016/j.fct.2013.10.027", "24416779"]}, {"Citation": "Krsti\u0107 D.Z., \u010colovi\u0107 M., Kralj M.B., Franko M., Krinulovi\u0107 K., Treb\u0161e P., Vasi\u0107 V. Inhibition of AChE by malathion and some structurally similar compounds. J. Enzym. Inhib. Med. Chem. 2008;23:562\u2013573. doi: 10.1080/14756360701632031.", "ArticleIdList": ["10.1080/14756360701632031", "18608787"]}, {"Citation": "Hassan S.H.A., Fry J.R., Abu Bakar M.F. Phytochemicals Content, Antioxidant Activity and Acetylcholinesterase Inhibition Properties of IndigenousGarcinia parvifoliaFruit. BioMed Res. Int. 2013;2013:1\u20137. doi: 10.1155/2013/138950.", "ArticleIdList": ["10.1155/2013/138950", "PMC3832992", "24288662"]}, {"Citation": "Ahmad S.S., Waheed T., Rozeen S., Mahmood S., Kamal M.A. Therapeutic Study of Phytochemicals Against Cancer and Alzheimer\u2019s Disease Management. Curr. Drug Metab. 2020;20:1006\u20131013. doi: 10.2174/1389200221666200103092719.", "ArticleIdList": ["10.2174/1389200221666200103092719", "31902351"]}, {"Citation": "Calfio C., Gonzalez A., Singh S.K., Rojo L.E., Maccioni R.B. The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer\u2019s Disease. J. Alzheimer\u2019s Dis. 2020;77:33\u201351. doi: 10.3233/JAD-200443.", "ArticleIdList": ["10.3233/JAD-200443", "32651325"]}, {"Citation": "Gregory J., Vengalasetti Y., Bredesen D., Rao R. Neuroprotective Herbs for the Management of Alzheimer\u2019s Disease. Biomolecules. 2021;11:543. doi: 10.3390/biom11040543.", "ArticleIdList": ["10.3390/biom11040543", "PMC8068256", "33917843"]}, {"Citation": "Karthika C., Appu A.P., Akter R., Rahman H., Tagde P., Ashraf G.M., Abdel-Daim M.M., Hassan S.S.U., Abid A., Bungau S. Potential innovation against Alzheimer\u2019s disorder: A tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery. Environ. Sci. Pollut. Res. 2022;29:10950\u201310965. doi: 10.1007/s11356-021-17830-7.", "ArticleIdList": ["10.1007/s11356-021-17830-7", "35000160"]}, {"Citation": "Hartman R.E. Effects and mechanisms of actions of phytochemicals on Alzheimer rsquo s disease neuropathology. Front. Biosci. 2018;10:300\u2013333. doi: 10.2741/e824.", "ArticleIdList": ["10.2741/e824", "28930620"]}, {"Citation": "Camandola S., Plick N., Mattson M.P. Impact of Coffee and Cacao Purine Metabolites on Neuroplasticity and Neurodegenerative Disease. Neurochem. Res. 2018;44:214\u2013227. doi: 10.1007/s11064-018-2492-0.", "ArticleIdList": ["10.1007/s11064-018-2492-0", "PMC6082740", "29417473"]}, {"Citation": "Fernando W.M., Somaratne G., Goozee K.G., Williams S., Singh H., Martins R.N. Diabetes and Alzheimer\u2019s Disease: Can Tea Phytochemicals Play a Role in Prevention? J. Alzheimer\u2019s Dis. 2017;59:481\u2013501. doi: 10.3233/JAD-161200.", "ArticleIdList": ["10.3233/JAD-161200", "28582855"]}, {"Citation": "Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol. Sci. 1991;12:383\u2013388. doi: 10.1016/0165-6147(91)90609-V.", "ArticleIdList": ["10.1016/0165-6147(91)90609-V", "1763432"]}, {"Citation": "Taylor H.A., Przemylska L., Clavane E.M., Meakin P.J. BACE1: More than just a beta-secretase. Obes. Rev. 2022;23:e13430. doi: 10.1111/obr.13430.", "ArticleIdList": ["10.1111/obr.13430", "35119166"]}, {"Citation": "K\u00f6nig G., M\u00f6nning U., Czech C., Prior R., Banati R., Schreiter-Gasser U., Bauer J., Masters C., Beyreuther K. Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J. Biol. Chem. 1992;267:10804\u201310809. doi: 10.1016/S0021-9258(19)50090-4.", "ArticleIdList": ["10.1016/S0021-9258(19)50090-4", "1587857"]}, {"Citation": "Norstrom E. Metabolic processing of the amyloid precursor protein\u2013\u2013New pieces of the Alzheimer\u2019s puzzle. Discov. Med. 2017;23:269\u2013276.", "ArticleIdList": ["28595039"]}, {"Citation": "Sathya M., Premkumar P., Karthick C., Moorthi P., Jayachandran K., Anusuyadevi M. BACE1 in Alzheimer\u2019s disease. Clin. Chim. Acta. 2012;414:171\u2013178. doi: 10.1016/j.cca.2012.08.013.", "ArticleIdList": ["10.1016/j.cca.2012.08.013", "22926063"]}, {"Citation": "He X., Zhu G., Koelsch G., Rodgers K.K., Zhang X.C., Tang J. Biochemical and Structural Characterization of the Interaction of Memapsin 2 (\u03b2-Secretase) Cytosolic Domain with the VHS Domain of GGA Proteins. Biochemistry. 2003;42:12174\u201312180. doi: 10.1021/bi035199h.", "ArticleIdList": ["10.1021/bi035199h", "14567678"]}, {"Citation": "Hrabinova M., Pejchal J., Kucera T., Juna D., Schmidt M., Soukup O. Is It the Twilight of BACE1 Inhibitors? Curr. Neuropharmacol. 2020;19:61\u201377. doi: 10.2174/1570159X18666200503023323.", "ArticleIdList": ["10.2174/1570159X18666200503023323", "PMC7903497", "32359337"]}, {"Citation": "Kennedy M.E., Wang W., Song L., Lee J., Zhang L., Wong G., Wang L., Parker E. Measuring human \u03b2-secretase (BACE1) activity using homogeneous time-resolved fluorescence. Anal. Biochem. 2003;319:49\u201355. doi: 10.1016/S0003-2697(03)00253-7.", "ArticleIdList": ["10.1016/S0003-2697(03)00253-7", "12842106"]}, {"Citation": "Eketj\u00e4ll S., Janson J., Kaspersson K., Bogstedt A., Jeppsson F., F\u00e4lting J., Haeberlein S.B., Kugler A.R., Alexander R.C., Cebers G. AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics. J. Alzheimer\u2019s Dis. 2016;50:1109\u20131123. doi: 10.3233/JAD-150834.", "ArticleIdList": ["10.3233/JAD-150834", "PMC4927864", "26890753"]}, {"Citation": "Neumann U., Ufer M., Jacobson L., Rouzade-Dominguez M., Huledal G., Kolly C., L\u00fc\u00f6nd R.M., Machauer R., Veenstra S.J., Hurth K., et al. The BACE -1 inhibitor CNP 520 for prevention trials in Alzheimer\u2019s disease. EMBO Mol. Med. 2018;10:e9316. doi: 10.15252/emmm.201809316.", "ArticleIdList": ["10.15252/emmm.201809316", "PMC6220303", "30224383"]}, {"Citation": "Kennedy M.E., Stamford A.W., Chen X., Cox K., Cumming J.N., Dockendorf M.F., Egan M., Ereshefsky L., Hodgson R.A., Hyde L.A., et al. The BACE1 inhibitor verubecestat (MK-8931) reduces CNS \u03b2-amyloid in animal models and in Alzheimer\u2019s disease patients. Sci. Transl. Med. 2016;8:363ra150. doi: 10.1126/scitranslmed.aad9704.", "ArticleIdList": ["10.1126/scitranslmed.aad9704", "27807285"]}, {"Citation": "Sakamoto K., Matsuki S., Matsuguma K., Yoshihara T., Uchida N., Azuma F., Russell M., Hughes G., Haeberlein S.B., Alexander R.C., et al. BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid A\u03b2 Peptides. J. Clin. Pharmacol. 2017;57:1460\u20131471. doi: 10.1002/jcph.950.", "ArticleIdList": ["10.1002/jcph.950", "28618005"]}, {"Citation": "Timmers M., Van Broeck B., Ramael S., Slemmon J., De Waepenaert K., Russu A., Bogert J., Stieltjes H., Shaw L.M., Engelborghs S., et al. Profiling the dynamics of CSF and plasma A\u03b2 reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor. Alzheimer\u2019s Dementia: Transl. Res. Clin. Interv. 2016;2:202\u2013212. doi: 10.1016/j.trci.2016.08.001.", "ArticleIdList": ["10.1016/j.trci.2016.08.001", "PMC5651349", "29067308"]}, {"Citation": "Lopez C.L., Tariot P.N., Caputo A., Langbaum J.B., Liu F., Riviere M., Langlois C., Rouzade-Dominguez M., Zalesak M., Hendrix S., et al. The Alzheimer\u2019s Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia: Transl. Res. Clin. Interv. 2019;5:216\u2013227. doi: 10.1016/j.trci.2019.02.005.", "ArticleIdList": ["10.1016/j.trci.2019.02.005", "PMC6562315", "31211217"]}, {"Citation": "Zhang C. Natural compounds that modulate BACE1-processing of amyloid-beta precursor protein in Alzheimer\u2019s disease. Discov. Med. 2012;14:189\u2013197.", "ArticleIdList": ["23021373"]}, {"Citation": "Youn K., Park J.-H., Lee S., Lee S., Lee J., Yun E.-Y., Jeong W.-S., Jun M. BACE1 Inhibition by Genistein: Biological Evaluation, Kinetic Analysis, and Molecular Docking Simulation. J. Med. Food. 2018;21:416\u2013420. doi: 10.1089/jmf.2017.4068.", "ArticleIdList": ["10.1089/jmf.2017.4068", "29444415"]}, {"Citation": "Naushad M., Durairajan S.S.K., Bera A.K., Senapati S., Li M. Natural Compounds with Anti-BACE1 Activity as Promising Therapeutic Drugs for Treating Alzheimer\u2019s Disease. Planta Med. 2019;85:1316\u20131325. doi: 10.1055/a-1019-9819.", "ArticleIdList": ["10.1055/a-1019-9819", "31618777"]}, {"Citation": "Yu T., Paudel P., Seong S.H., Kim J.A., Jung H.A., Choi J.S. Computational insights into \u03b2-site amyloid precursor protein enzyme 1 (BACE1) inhibition by tanshinones and salvianolic acids from Salvia miltiorrhiza via molecular docking simulations. Comput. Biol. Chem. 2018;74:273\u2013285. doi: 10.1016/j.compbiolchem.2018.04.008.", "ArticleIdList": ["10.1016/j.compbiolchem.2018.04.008", "29679864"]}, {"Citation": "Youdim M.B.H., Edmondson D., Tipton K.F. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 2006;7:295\u2013309. doi: 10.1038/nrn1883.", "ArticleIdList": ["10.1038/nrn1883", "16552415"]}, {"Citation": "Shih J.C., Chen K., Ridd M.J. MONOAMINE OXIDASE: From Genes to Behavior. Annu. Rev. Neurosci. 1999;22:197\u2013217. doi: 10.1146/annurev.neuro.22.1.197.", "ArticleIdList": ["10.1146/annurev.neuro.22.1.197", "PMC2844879", "10202537"]}, {"Citation": "Tipton K.F., Boyce S., O\u2019Sullivan J., Davey G.P., Healy J. Monoamine Oxidases: Certainties and Uncertainties. Curr. Med. Chem. 2004;11:1965\u20131982. doi: 10.2174/0929867043364810.", "ArticleIdList": ["10.2174/0929867043364810", "15279561"]}, {"Citation": "Kumar B., Dwivedi A.R., Sarkar B., Gupta S.K., Krishnamurthy S., Mantha A.K., Parkash J., Kumar V. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer\u2019s Disease. ACS Chem. Neurosci. 2018;10:252\u2013265. doi: 10.1021/acschemneuro.8b00220.", "ArticleIdList": ["10.1021/acschemneuro.8b00220", "30296051"]}, {"Citation": "Orhan I.E. Potential of Natural Products of Herbal Origin as Monoamine Oxidase Inhibitors. Curr. Pharm. Des. 2015;22:268\u2013276. doi: 10.2174/1381612822666151112150612.", "ArticleIdList": ["10.2174/1381612822666151112150612", "26561069"]}, {"Citation": "Juvekar A.R., Khatri D. Kinetics of inhibition of monoamine oxidase using curcumin and ellagic acid. Pharmacogn. Mag. 2016;12:116\u2013120. doi: 10.4103/0973-1296.182168.", "ArticleIdList": ["10.4103/0973-1296.182168", "PMC4883067", "27279695"]}, {"Citation": "Baek S.C., Ryu H.W., Kang M.-G., Lee H., Park D., Cho M.-L., Oh S.-R., Kim H. Selective inhibition of monoamine oxidase A by chelerythrine, an isoquinoline alkaloid. Bioorganic Med. Chem. Lett. 2018;28:2403\u20132407. doi: 10.1016/j.bmcl.2018.06.023.", "ArticleIdList": ["10.1016/j.bmcl.2018.06.023", "29925480"]}, {"Citation": "Chaurasiya N.D., Midiwo J., Pandey P., Bwire R.N., Doerksen R.J., Muhammad I., Tekwani B.L. Selective Interactions of O-Methylated Flavonoid Natural Products with Human Monoamine Oxidase-A and -B. Molecules. 2020;25:5358. doi: 10.3390/molecules25225358.", "ArticleIdList": ["10.3390/molecules25225358", "PMC7697615", "33212830"]}, {"Citation": "Santos G., Giraldez-Alvarez L.D., Avila-Rodr\u00edguez M., Capani F., Galembeck E., Neto A.G., Barreto G.E., Andrade B. SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson. Front. Aging Neurosci. 2016;8:97. doi: 10.3389/fnagi.2016.00097.", "ArticleIdList": ["10.3389/fnagi.2016.00097", "PMC4852538", "27199743"]}, {"Citation": "Gonz\u00e1lez-Mu\u00f1oz G.C., Arce M.P., P\u00e9rez C., Romero A., Villarroya M., Lopez M.G., Conde S., Rodr\u00edguez-Franco M.I. Dibenzo[1,4,5]thiadiazepine: A hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseases. Eur. J. Med. Chem. 2014;81:350\u2013358. doi: 10.1016/j.ejmech.2014.04.075.", "ArticleIdList": ["10.1016/j.ejmech.2014.04.075", "24858540"]}, {"Citation": "Kaufmann D., Kaur Dogra A., Tahrani A., Herrmann F., Wink M. Extracts from Traditional Chinese Medicinal Plants Inhibit Acetylcholinesterase, a Known Alzheimer\u2019s Disease Target. Molecules. 2016;21:1161. doi: 10.3390/molecules21091161.", "ArticleIdList": ["10.3390/molecules21091161", "PMC6273583", "27589716"]}, {"Citation": "Singh A.K., Singh S.K., Nandi M.K., Mishra G., Maurya A., Rai A., Rai G.K., Awasthi R., Sharma B., Kulkarni G.T. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer\u2019s disease. Central Nerv. Syst. Agents Med. Chem. 2019;19:154\u2013170. doi: 10.2174/1871524919666190820160053.", "ArticleIdList": ["10.2174/1871524919666190820160053", "31429696"]}, {"Citation": "Howes M.-J.R., Simmonds M.S. The role of phytochemicals as micronutrients in health and disease. Curr. Opin. Clin. Nutr. Metab. Care. 2014;17:558\u2013566. doi: 10.1097/MCO.0000000000000115.", "ArticleIdList": ["10.1097/MCO.0000000000000115", "25252018"]}, {"Citation": "Larit F., Elokely K.M., Chaurasiya N.D., Benyahia S., Nael M.A., Leon F., Abu-Darwish M.S., Efferth T., Wang Y.-H., Belouahem-Abed D., et al. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants. Phytomedicine. 2017;40:27\u201336. doi: 10.1016/j.phymed.2017.12.032.", "ArticleIdList": ["10.1016/j.phymed.2017.12.032", "PMC5947877", "29496172"]}, {"Citation": "Sharifi-Rad J., Quispe C., Imran M., Rauf A., Nadeem M., Gondal T.A., Ahmad B., Atif M., Mubarak M.S., Sytar O., et al. Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits. Oxidative Med. Cell. Longev. 2021;2021:1\u201336. doi: 10.1155/2021/3268136.", "ArticleIdList": ["10.1155/2021/3268136", "PMC8315847", "34336089"]}, {"Citation": "Menze E.T., Tadros M.G., Abdel-Tawab A.M., Khalifa A. Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats. NeuroToxicology. 2012;33:1265\u20131275. doi: 10.1016/j.neuro.2012.07.007.", "ArticleIdList": ["10.1016/j.neuro.2012.07.007", "22850463"]}, {"Citation": "Chakraborty S., Bandyopadhyay J., Chakraborty S., Basu S. Multi-target screening mines hesperidin as a multi-potent inhibitor: Implication in Alzheimer\u2019s disease therapeutics. Eur. J. Med. Chem. 2016;121:810\u2013822. doi: 10.1016/j.ejmech.2016.03.057.", "ArticleIdList": ["10.1016/j.ejmech.2016.03.057", "27068363"]}, {"Citation": "Parhiz H., Roohbakhsh A., Soltani F., Rezaee R., Iranshahi M. Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental Models. Phytotherapy Res. 2014;29:323\u2013331. doi: 10.1002/ptr.5256.", "ArticleIdList": ["10.1002/ptr.5256", "25394264"]}, {"Citation": "Carmona V., Mart\u00edn-Arag\u00f3n S., Goldberg J., Schubert D., Bermejo-Besc\u00f3s P. Several targets involved in Alzheimer\u2019s disease amyloidogenesis are affected by morin and isoquercitrin. Nutr. Neurosci. 2018;23:575\u2013590. doi: 10.1080/1028415X.2018.1534793.", "ArticleIdList": ["10.1080/1028415X.2018.1534793", "30326823"]}, {"Citation": "Rajput S.A., Wang X.-Q., Yan H.-C. Morin hydrate: A comprehensive review on novel natural dietary bioactive compound with versatile biological and pharmacological potential. Biomed. Pharmacother. 2021;138:111511. doi: 10.1016/j.biopha.2021.111511.", "ArticleIdList": ["10.1016/j.biopha.2021.111511", "33744757"]}, {"Citation": "Shal B., Ding W., Ali H., Kim Y.S., Khan S. Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer\u2019s Disease. Front. Pharmacol. 2018;9:548. doi: 10.3389/fphar.2018.00548.", "ArticleIdList": ["10.3389/fphar.2018.00548", "PMC5986949", "29896105"]}, {"Citation": "Dar N.J., Hamid A., Ahmad M. Pharmacologic overview of Withania somnifera, the Indian Ginseng. Exp. 2015;72:4445\u20134460. doi: 10.1007/s00018-015-2012-1.", "ArticleIdList": ["10.1007/s00018-015-2012-1", "26306935"]}, {"Citation": "Fang J., Liu R., Tian Q., Hong X.-P., Wang S.-H., Cao F.-Y., Pan X.-P., Wang J.-Z. Dehydroevodiamine attenuates calyculin A-induced tau hyperphos-phorylation in rat brain slices. Acta Pharmacol. Sin. 2007;28:1717\u20131723. doi: 10.1111/j.1745-7254.2007.00655.x.", "ArticleIdList": ["10.1111/j.1745-7254.2007.00655.x", "17959021"]}, {"Citation": "Wang C.-Y., Zheng W., Wang T., Xie J.-W., Wang S.-L., Zhao B.-L., Teng W.-P., Wang Z.-Y. Huperzine A Activates Wnt/\u03b2-Catenin Signaling and Enhances the Nonamyloidogenic Pathway in an Alzheimer Transgenic Mouse Model. Neuropsychopharmacology. 2011;36:1073\u20131089. doi: 10.1038/npp.2010.245.", "ArticleIdList": ["10.1038/npp.2010.245", "PMC3077275", "21289607"]}, {"Citation": "Yang Z.-D., Zhang X., Du J., Ma Z.-J., Guo F., Li S., Yao X.-J. An aporphine alkaloid from Nelumbo nucifera as an acetylcholinesterase inhibitor and the primary investigation for structure\u2013activity correlations. Nat. Prod. Res. 2012;26:387\u2013392. doi: 10.1080/14786419.2010.487188.", "ArticleIdList": ["10.1080/14786419.2010.487188", "21732870"]}, {"Citation": "Xian Y.-F., Mao Q.-Q., Wu J.C., Su Z.-R., Chen J.-N., Lai X.-P., Ip S.-P., Lin Z.-X. Isorhynchophylline Treatment Improves the Amyloid-\u03b2-Induced Cognitive Impairment in Rats via Inhibition of Neuronal Apoptosis and Tau Protein Hyperphosphorylation. J. Alzheimer\u2019s Dis. 2014;39:331\u2013346. doi: 10.3233/JAD-131457.", "ArticleIdList": ["10.3233/JAD-131457", "24164737"]}, {"Citation": "Haj E., Losev Y., KrishnaKumar V.G., Pichinuk E., Engel H., Raveh A., Gazit E., Segal D. Integrating in vitro and in silico approaches to evaluate the \u201cdual functionality\u201d of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils. Biochim. Et Biophys. Acta (BBA) Gen. Subj. 2018;1862:1565\u20131575. doi: 10.1016/j.bbagen.2018.04.001.", "ArticleIdList": ["10.1016/j.bbagen.2018.04.001", "29634991"]}, {"Citation": "L\u00f3pez S., Bastida J., Viladomat F., Codina C. Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. Life Sci. 2002;71:2521\u20132529. doi: 10.1016/S0024-3205(02)02034-9.", "ArticleIdList": ["10.1016/S0024-3205(02)02034-9", "12270757"]}, {"Citation": "Rollinger J.M., Schuster D., Baier E., Ellmerer E.P., Langer T., Stuppner H. Taspine: Bioactivity-Guided Isolation and Molecular Ligand\u2212Target Insight of a Potent Acetylcholinesterase Inhibitor from Magnolia x soulangiana. J. Nat. Prod. 2006;69:1341\u20131346. doi: 10.1021/np060268p.", "ArticleIdList": ["10.1021/np060268p", "PMC3526713", "16989531"]}, {"Citation": "Ahmad S., Khan M., Ahmad K., Lim J.-H., Shaikh S., Lee E.-J., Choi I. Biocomputational Screening of Natural Compounds against Acetylcholinesterase. Molecules. 2021;26:2641. doi: 10.3390/molecules26092641.", "ArticleIdList": ["10.3390/molecules26092641", "PMC8125523", "33946559"]}, {"Citation": "Qi T., Li H., Li S. Indirubin improves antioxidant and anti-inflammatory functions in lipopolysaccharide-challenged mice. Oncotarget. 2017;8:36658\u201336663. doi: 10.18632/oncotarget.17560.", "ArticleIdList": ["10.18632/oncotarget.17560", "PMC5482685", "28525368"]}, {"Citation": "Ahmad S.S., Sinha M., Ahmad K., Khalid M., Choi I. Study of Caspase 8 Inhibition for the Management of Alzheimer\u2019s Disease: A Molecular Docking and Dynamics Simulation. Molecules. 2020;25:2071. doi: 10.3390/molecules25092071.", "ArticleIdList": ["10.3390/molecules25092071", "PMC7249184", "32365525"]}, {"Citation": "Ahmad S.S., Akhtar S., Rizvi S.M.D., Kamal M.A., Sayeed U., Khan M.K.A., Siddiqui M.H., Arif J.M. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer\u2019s Potential Targeting BACE-1 Enzyme: A Case Computational Study. Curr. Comput. Aided-Drug Des. 2017;13:311\u2013318. doi: 10.2174/1573409913666170414123825.", "ArticleIdList": ["10.2174/1573409913666170414123825", "28413992"]}, {"Citation": "Kou X., Chen N. Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer\u2019s Disease. Nutrients. 2017;9:927. doi: 10.3390/nu9090927.", "ArticleIdList": ["10.3390/nu9090927", "PMC5622687", "28837083"]}, {"Citation": "Tang M., Taghibiglou C. The Mechanisms of Action of Curcumin in Alzheimer\u2019s Disease. J. Alzheimer\u2019s Dis. 2017;58:1003\u20131016. doi: 10.3233/JAD-170188.", "ArticleIdList": ["10.3233/JAD-170188", "28527218"]}, {"Citation": "Ji H.-F., Zhang H.-Y. Multipotent natural agents to combat Alzheimer\u2019s disease. Functional spectrum and structural features. Acta Pharmacol. Sin. 2008;29:143\u2013151. doi: 10.1111/j.1745-7254.2008.00752.x.", "ArticleIdList": ["10.1111/j.1745-7254.2008.00752.x", "18215342"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "15"}, {"Year": "2022", "Month": "5", "Day": "23"}, {"Year": "2022", "Month": "6", "Day": "8"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "1", "Minute": "19"}, {"Year": "2022", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["35807418", "PMC9268689", "10.3390/molecules27134175", "molecules27134175"]}}], "PubmedBookArticle": []}